Adam Kruszewski
CEO
Orphinic Scientific
The startup develops a biotech portfolio platform that focuses on rare diseases, specifically targeting orphan diseases with significant unmet medical needs in the clinical trial phase. By providing clients with ready-to-manufacture medical technologies, the platform accelerates the availability of effective treatments for patients suffering from these conditions.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$2.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a biotech portfolio platform that focuses on rare diseases, specifically targeting orphan diseases with significant unmet medical needs in the clinical trial phase. By providing clients with ready-to-manufacture medical technologies, the platform accelerates the availability of effective treatments for patients suffering from these conditions.